Jupiter Neurosciences, Inc. is a clinical-stage research and development pharmaceutical company. The Company has developed a resveratrol platform product targeting the treatment of neuro-inflammation. Its product, JOTROL, has many potential indications of use for rare diseases, which primarily targets Mucopolysaccharidoses Type 1, Friedreich's Ataxia, and Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like episodes (MELAS). In the larger disease areas, it primarily targets Parkinson’s Disease and Mild Cognitive Impairment/early Alzheimer’s disease. The Company has designated the different indications with project numbers, JNS101 - JNS115. JOTROL is a micellar non-aqueous solution of resveratrol delivered in a soft gel capsule. Each capsule includes 100mg of resveratrol. It has a worldwide license from Aquanova AG, the patent holder of micellar technologies, to develop, manufacture, distribute and sell JOTROL.

Jupiter Neurosciences Inc Profile



Ticker SymbolJUNS

Company nameJupiter Neurosciences Inc

IPO dateDec 03, 2024

CEORosen (Christer)

Number of employees4

Security typeOrdinary Share

Fiscal year-endDec 03

Address1001 North US HWY 1, Suite 504

CityPALM BEACH GARDENS

Stock exchangeNASDAQ OMX - NASDAQ BASIC

CountryUnited States of America

Postal code33477

Phone15614066154

Websitehttps://jupiterneurosciences.com/

Ticker SymbolJUNS

IPO dateDec 03, 2024

CEORosen (Christer)

Company Executives of Jupiter Neurosciences Inc



Name

Name/Position

Position

Shareholding

Change

Mr. Christer Rosen

Chairman of the Board, Chief Executive Officer, Co-Founder

141.06K

-4.70%

Mr. Christer Rosen

Chairman of the Board, Chief Executive Officer, Co-Founder

141.06K

-4.70%

Mr. Christer Rosen

Chairman of the Board, Chief Executive Officer, Co-Founder

141.06K

-4.70%

Mr. Alexander Gustaf Erik Rosen

Co-Founder, Chief Administrative Officer

6.04K

-36.34%

Mr. Alexander Gustaf Erik Rosen

Co-Founder, Chief Administrative Officer

6.04K

-36.34%

Mr. Alexander Gustaf Erik Rosen

Co-Founder, Chief Administrative Officer

6.04K

-36.34%

Ms. Allison W. Brady

Independent Director

290.00

-358.62%

Mr. Holger Weis, CPA

Independent Director

144.00

-794.44%

Mr. Holger Weis, CPA

Independent Director

144.00

-794.44%

Mr. Holger Weis, CPA

Independent Director

144.00

-794.44%

Name

Name/Position

Position

Shareholding

Change

Mr. Christer Rosen

Chairman of the Board, Chief Executive Officer, Co-Founder

141.06K

-4.70%

Mr. Christer Rosen

Chairman of the Board, Chief Executive Officer, Co-Founder

141.06K

-4.70%

Mr. Christer Rosen

Chairman of the Board, Chief Executive Officer, Co-Founder

141.06K

-4.70%

Mr. Alexander Gustaf Erik Rosen

Co-Founder, Chief Administrative Officer

6.04K

-36.34%

Mr. Alexander Gustaf Erik Rosen

Co-Founder, Chief Administrative Officer

6.04K

-36.34%

Mr. Alexander Gustaf Erik Rosen

Co-Founder, Chief Administrative Officer

6.04K

-36.34%

FAQs

Who are the top five shareholders of Jupiter Neurosciences Inc?



The top five shareholders of Jupiter Neurosciences Inc are: Mr. Christer Rosen

How many institutions hold shares of Jupiter Neurosciences Inc (JUNS)?



As of 2026Q1, 21 institutions hold shares of Jupiter Neurosciences Inc, with a combined market value of approximately 2.06M, accounting for 5.68% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 1545404.00.